Sudan Loganathan
Stock Analyst at Stephens & Co.
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NRIX Nurix Therapeutics | Reiterates: Overweight | 30 30 | 9.64 | 211.2% | 4 | Jul 10, 2025 | |
EXEL Exelixis | Upgrades: Overweight | 29 60 | 37.43 | 60.3% | 5 | Jun 24, 2025 | |
DCTH Delcath Systems | Reiterates: Overweight | 25 25 | 10.51 | 137.87% | 3 | Jun 23, 2025 | |
BPMC Blueprint Medicines | Downgrades: Equal-Weight | 150 135 | 129.46 | 4.28% | 3 | Jun 3, 2025 | |
ELEV Elevation Oncology | Downgrades: Equal-Weight | 5 5 | n/a | n/a | 4 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 30 30 | 9.66 | 210.56% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 33 | 19.69 | 67.6% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 8 | 2.67 | 199.63% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 50 50 | 22.84 | 118.91% | 2 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 15 15 | 7.46 | 101.07% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 37.69 | 59.19% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.45 | 244.83% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 4 | 2.42 | 65.29% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 6.58 | 735.87% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 1.05 | 1138.1% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 100 100 | 7.48 | 1236.9% | 2 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 1.45 | 1279.31% | 1 | May 14, 2024 |